Glenmark eyes cream of derma crop with US FTF for generic Finacea
This article was originally published in Scrip
Executive Summary
Glenmark Generics believes it may be the first to file an ANDA for a generic version of rosacea therapy, Finacea (azelaic acid), entitling the Indian firm to 180days of marketing exclusivity in the US.